Market News

Prescott Group Capital Management Has Lifted Its Skechers U S A (SKX) Holding; Last Week EyePoint Pharmaceuticals, Inc. (PSDV) Coverage

EyePoint Pharmaceuticals, Inc. (NASDAQ:PSDV) Logo

Prescott Group Capital Management Llc increased Skechers U S A Inc (SKX) stake by 49.84% reported in 2017Q4 SEC filing. Prescott Group Capital Management Llc acquired 16,000 shares as Skechers U S A Inc (SKX)’s stock rose 0.47%. The Prescott Group Capital Management Llc holds 48,100 shares with $1.82 million value, up from 32,100 last quarter. Skechers U S A Inc now has $4.91 billion valuation. The stock decreased 27.04% or $11.38 during the last trading session, reaching $30.7. About 37.14M shares traded or 1236.21% up from the average. Skechers U.S.A., Inc. (NYSE:SKX) has risen 33.31% since April 22, 2017 and is uptrending. It has outperformed by 21.76% the S&P500.

Among 6 analysts covering pSivida (NASDAQ:PSDV), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. pSivida had 20 analyst reports since October 15, 2015 according to SRatingsIntel. On Tuesday, July 11 the stock rating was maintained by H.C. Wainwright with “Buy”. H.C. Wainwright maintained EyePoint Pharmaceuticals, Inc. (NASDAQ:PSDV) on Friday, December 15 with “Buy” rating. The stock of EyePoint Pharmaceuticals, Inc. (NASDAQ:PSDV) has “Buy” rating given on Monday, February 5 by FBR Capital. The stock of EyePoint Pharmaceuticals, Inc. (NASDAQ:PSDV) earned “Outperform” rating by FBR Capital on Thursday, October 15. As per Tuesday, May 30, the company rating was maintained by H.C. Wainwright. The firm earned “Buy” rating on Tuesday, June 13 by FBR Capital. The rating was maintained by H.C. Wainwright with “Buy” on Wednesday, June 14. The stock has “Buy” rating by H.C. Wainwright on Friday, June 23. As per Tuesday, June 13, the company rating was maintained by Ladenburg. The stock of EyePoint Pharmaceuticals, Inc. (NASDAQ:PSDV) has “Buy” rating given on Tuesday, September 12 by H.C. Wainwright. See EyePoint Pharmaceuticals, Inc. (NASDAQ:PSDV) latest ratings:

20/03/2018 Broker: H.C. Wainwright Rating: Buy New Target: $5.0 Maintain
08/02/2018 Broker: H.C. Wainwright Rating: Buy New Target: $5.0 Maintain
05/02/2018 Broker: FBR Capital Rating: Buy New Target: $5.0 Initiate
09/01/2018 Broker: H.C. Wainwright Rating: Buy New Target: $5.0 Maintain
15/12/2017 Broker: H.C. Wainwright Rating: Buy New Target: $5.0 Maintain
04/12/2017 Broker: FBR Capital Rating: Buy New Target: $5.0
08/11/2017 Broker: H.C. Wainwright Rating: Buy New Target: $5.0 Maintain
08/11/2017 Broker: Laidlaw Rating: Buy New Target: $5 Initiates Coverage On

Among 19 analysts covering Skechers Usa Inc. (NYSE:SKX), 15 have Buy rating, 0 Sell and 4 Hold. Therefore 79% are positive. Skechers Usa Inc. had 71 analyst reports since July 22, 2015 according to SRatingsIntel. As per Wednesday, April 18, the company rating was reinitiated by Citigroup. Citigroup upgraded the shares of SKX in report on Thursday, June 1 to “Buy” rating. As per Wednesday, January 3, the company rating was maintained by Wedbush. The rating was downgraded by Susquehanna on Wednesday, March 29 to “Negative”. The stock has “Outperform” rating by Macquarie Research on Thursday, April 7. The rating was maintained by Wells Fargo with “Market Perform” on Friday, October 20. As per Friday, July 21, the company rating was maintained by Wedbush. Monness Crespi maintained Skechers U.S.A., Inc. (NYSE:SKX) on Friday, December 1 with “Buy” rating. The firm has “Equal-Weight” rating by Morgan Stanley given on Friday, October 20. The rating was initiated by Argus Research on Tuesday, October 13 with “Buy”.

Investors sentiment increased to 1.34 in Q4 2017. Its up 0.07, from 1.27 in 2017Q3. It increased, as 25 investors sold SKX shares while 86 reduced holdings. 76 funds opened positions while 73 raised stakes. 110.47 million shares or 8.33% more from 101.97 million shares in 2017Q3 were reported. 20,988 were reported by Lpl Fincl Lc. Retail Bank Of America Corp De holds 0.01% of its portfolio in Skechers U.S.A., Inc. (NYSE:SKX) for 1.39M shares. Amica Mutual holds 0.62% or 165,022 shares. 134,278 are owned by Pub Employees Retirement System Of Ohio. Credit Suisse Ag owns 497,768 shares. Moreover, Oregon Pub Employees Retirement Fund has 0.02% invested in Skechers U.S.A., Inc. (NYSE:SKX) for 49,322 shares. Pnc Fincl Services Incorporated owns 23,177 shares or 0% of their US portfolio. Thompson Investment Mngmt Inc owns 132,476 shares or 0.88% of their US portfolio. Invesco invested 0% of its portfolio in Skechers U.S.A., Inc. (NYSE:SKX). Menta Capital invested in 0.07% or 10,109 shares. Point72 Asia (Hong Kong) Limited holds 35 shares or 0% of its portfolio. Fund Management invested in 186,082 shares or 0.04% of the stock. Brown Brothers Harriman And Com owns 255 shares. Canada Pension Plan Board owns 0.05% invested in Skechers U.S.A., Inc. (NYSE:SKX) for 721,100 shares. Millennium Mngmt Limited Com has invested 0.08% of its portfolio in Skechers U.S.A., Inc. (NYSE:SKX).

Since October 24, 2017, it had 0 insider buys, and 6 insider sales for $3.94 million activity. NASON MARK A sold 16,701 shares worth $673,687. Erlich Morton D sold $134,620 worth of Skechers U.S.A., Inc. (NYSE:SKX) on Wednesday, November 22. WEINBERG DAVID sold $935,158 worth of stock. On Friday, March 2 PACCIONE PHILLIP sold $663,113 worth of Skechers U.S.A., Inc. (NYSE:SKX) or 17,432 shares. The insider SISKIND RICHARD sold 25,500 shares worth $851,700. 37,814 shares were sold by GREENBERG ROBERT, worth $1.53M.

Prescott Group Capital Management Llc decreased Wellcare Health Plans Inc (NYSE:WCG) stake by 16,000 shares to 22,043 valued at $4.43M in 2017Q4. It also reduced Blackhawk Network Hldgs Inc (NASDAQ:HAWK) stake by 12,343 shares and now owns 77,936 shares. Performant Finl Corp (NASDAQ:PFMT) was reduced too.

Investors sentiment increased to 0.92 in 2017 Q4. Its up 0.30, from 0.62 in 2017Q3. It improved, as 7 investors sold EyePoint Pharmaceuticals, Inc. shares while 6 reduced holdings. 5 funds opened positions while 7 raised stakes. 4.79 million shares or 10.05% more from 4.35 million shares in 2017Q3 were reported. Bridgeway Inc holds 0% in EyePoint Pharmaceuticals, Inc. (NASDAQ:PSDV) or 101,900 shares. State Street holds 0% or 35,800 shares in its portfolio. Savings Bank Of Mellon holds 0% or 28,885 shares. Utd Cap Advisers Limited Liability Company accumulated 10,000 shares or 0% of the stock. Citadel Advisors Limited Liability stated it has 15,691 shares. Paragon Cap Mngmt Limited invested 0.01% in EyePoint Pharmaceuticals, Inc. (NASDAQ:PSDV). Blackrock stated it has 0% in EyePoint Pharmaceuticals, Inc. (NASDAQ:PSDV). Group One Trading Lp reported 0% stake. Telemus Capital Limited Liability Corp has invested 0% in EyePoint Pharmaceuticals, Inc. (NASDAQ:PSDV). Susquehanna Intl Llp stated it has 0% in EyePoint Pharmaceuticals, Inc. (NASDAQ:PSDV). Matrix Asset Advsr Inc New York has 0% invested in EyePoint Pharmaceuticals, Inc. (NASDAQ:PSDV) for 28,500 shares. Massachusetts-based Geode Cap Mgmt Limited Company has invested 0% in EyePoint Pharmaceuticals, Inc. (NASDAQ:PSDV). 528 are held by Royal Comml Bank Of Canada. Vanguard Group accumulated 1.57 million shares. Northern Trust Corporation has invested 0% of its portfolio in EyePoint Pharmaceuticals, Inc. (NASDAQ:PSDV).

Since March 28, 2018, it had 1 insider purchase, and 0 insider sales for $9.47 million activity. On Wednesday, March 28 EW Healthcare Partners – L.P. bought $9.47M worth of EyePoint Pharmaceuticals, Inc. (NASDAQ:PSDV) or 8.61M shares.

pSivida Corp. develops sustained-release drug-delivery products for the treatment of chronic eye diseases in the United States and the United Kingdom. The company has market cap of $55.21 million. It offers ILUVIEN, an injectable, sustained-release micro-insert for use in treating vision impairment associated with diabetic macular edema; and Retisert for the treatment of posterior segment uveitis. It currently has negative earnings. The firm is also developing Durasert, an injectable, sustained-release micro-insert, which is in Phase III clinical trials for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye.

Skechers U.S.A., Inc. (NYSE:SKX) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *